B-cell receptor (BCR) signaling is a central pathogenetic pathway in chronic lymphocytic leukemia (CLL). Most CLL cells express BCRs of IgM and IgD isotypes, but the contribution of these isotypes to functional responses remains incompletely defined. We therefore investigated differences between IgM and IgD signaling in freshly isolated peripheral blood CLL cells and in CLL cells cultured with nurselike cells (NLC), a model that mimics the lymph node microenvironment. IgM signaling induced prolonged activation of ERK kinases, promoted CLL cell survival, CCL3 and CCL4 chemokine secretion, and down-regulation of BCL6, the transcriptional repressor of CCL3. In contrast, IgD signaling induced activation of the cytoskeletal protein HS1, along with F-actin polymerization, which resulted in rapid receptor internalization, and failure to support downstream responses including CLL cell survival and chemokine secretion. IgM and IgD receptor down-modulation, HS1 and ERK activation, chemokine secretion and BCL6 down-regulation were also observed when CLL cells were co-cultured with NLC. The BTK kinase inhibitor ibrutinib effectively inhibited both, IgM and IgD isotype signaling. In conclusion, through a variety of functional readouts, we demonstrate very distinct outcomes of IgM and IgD isotype activation in CLL cells, providing novel insight into the regulation of BCR signaling in CLL.